AVIEW LCS vs cmAngio®

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 60/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by Coreline Soft Co.
VS
by CureMetrix

AI Verdict

These tools offer adjacent functionalities within radiology AI for cardiovascular risk assessment, but they are not direct competitors. AVIEW LCS focuses on detecting lung nodules, COPD, and coronary artery calcification from CT scans, primarily for lung cancer screening programs. In contrast, cmAngio® specializes in identifying Breast Arterial Calcifications on mammograms to assess cardiovascular health specifically in women.

Choose AVIEW LCS if…

Choose AVIEW LCS if your primary need is a comprehensive AI-powered solution for lung cancer screening and detailed cardiopulmonary assessment from low-dose CT scans. This tool is ideal for identifying and analyzing lung nodules, quantifying emphysema, and scoring coronary artery calcification, providing a holistic view of a patient's thoracic health.

View AVIEW LCS →

Choose cmAngio® if…

Choose cmAngio® if your focus is on leveraging existing mammography data to assess women's cardiovascular health by detecting Breast Arterial Calcifications (BAC). This solution is best suited for integrating cardiovascular risk insights into routine breast cancer screening workflows without additional radiation or procedures, aiding in early risk assessment for women.

View cmAngio® →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature AVIEW LCS cmAngio®
Pricing Contact for pricing Paid, out-of-pocket
Deployment Cloud-based, Hybrid solution, Locally on dedicated hardware, Locally virtualized (virtual machine, Docker) Cloud-based, integrates with any DICOM-compliant viewer
BAA Available Yes AI-estimated Unknown
FDA Status Cleared AI-estimated Cleared AI-estimated
HIPAA Yes AI-estimated Yes AI-estimated

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature AVIEW LCS cmAngio®
Product Name AVIEW LCS cmAngiou00ae
Company Coreline Soft Co. CureMetrix
Primary Clinical Focus AI-powered solution for the detection and analysis of lung nodules, lung cancer, COPD, and coronary artery calcification from a single low-dose CT scan. FDA-cleared AI software for detecting Breast Arterial Calcifications (BAC) on mammograms, providing insights into cardiovascular health and aiding early risk assessment.
Key Detections/Analysis Automated lung nodule detection and analysis, Lung-RADS classification and reporting, Nodule volume quantification and 3D segmentation, Emphysema quantification (LAA index), Coronary Artery Calcification (CAC) scoring (Agatston, volume, mass), Automated comparison of nodules in follow-up CT scans. AI-based detection of Breast Arterial Calcifications (BAC), Provides visualization of BAC location on a scorecard.
Target Imaging Modality Low-dose CT scan Full-Field Digital Mammography (FFDM) and Digital Breast Tomosynthesis (DBT) exams

Videos

Demos, reviews, and walkthroughs featuring AVIEW LCS and cmAngio®.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

AVIEW LCS is an AI-powered solution for detecting and analyzing lung nodules, COPD, and coronary artery calcification from low-dose CT scans. cmAngiou00ae is FDA-cleared AI software for detecting Breast Arterial Calcifications (BAC) on mammograms, providing insights into cardiovascular health.
AVIEW LCS offers Coronary Artery Calcification (CAC) scoring (Agatston, volume, mass) from CT scans. cmAngiou00ae detects Breast Arterial Calcifications (BAC) on mammograms, aiding in early cardiovascular risk assessment without additional radiation.
AVIEW LCS indicates that a Business Associate Agreement (BAA) is available. For cmAngiou00ae, physicians need to contact the vendor directly for BAA details.
AVIEW LCS supports Cardiology, Oncology, Pulmonology, and Radiology specialties. cmAngiou00ae is relevant for Cardiology, Obstetrics & Gynecology, and Radiology.
AVIEW LCS provides quantification and scoring for Coronary Artery Calcification (CAC) from CT scans. cmAngiou00ae focuses on the AI-based detection of Breast Arterial Calcifications (BAC) on mammograms.

Backers

Who funded each tool's parent company.

cmAngio®

AI Tool Finder
AI-powered search. Results may not be comprehensive.